Is it Time to Dump Aethlon Medical, Inc. (AEMD) Stock After it Has Risen 32.61% in a Week?

The market has been down on Aethlon Medical, Inc. (AEMD) stock recently. AEMD gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Aethlon Medical, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on AEMD!

See Full AEMD Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With AEMD Stock Today?

Aethlon Medical, Inc. (AEMD) stock has risen 30.47% while the S&P 500 is lower by -0.94% as of 1:08 PM on Monday, Jan 30. AEMD is higher by $0.14 from the previous closing price of $0.47 on volume of 43,579,424 shares. Over the past year the S&P 500 has fallen -10.70% while AEMD is lower by -58.78%. AEMD lost -$0.74 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Aethlon Medical, Inc. click here.

More About Aethlon Medical, Inc.

Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment. Click Here to get the full Stock Report for Aethlon Medical, Inc. stock.